Journal of the American College of Surgeons
Volume 209, Issue 3, Supplement , Page S129, September 2009

A phase II study of neoadjuvant erlotinib (Tarceva) in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary results

The University of North Carolina at Chapel Hill, Chapel Hill, NC

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1072-7515(09)00900-4

doi:10.1016/j.jamcollsurg.2009.06.323

Journal of the American College of Surgeons
Volume 209, Issue 3, Supplement , Page S129, September 2009

Article Tools